222 filings
8-K
VTGN
VistaGen Therapeutics Inc
25 Apr 24
Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
7:18pm
8-K
VTGN
VistaGen Therapeutics Inc
1 Apr 24
Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder following Positive Results of PALISADE-2
5:25pm
8-K
VTGN
VistaGen Therapeutics Inc
13 Feb 24
Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update
4:33pm
8-K
VTGN
VistaGen Therapeutics Inc
8 Jan 24
Regulation FD Disclosure
6:37pm
8-K
VTGN
VistaGen Therapeutics Inc
3 Jan 24
Vistagen Receives Notice from European Patent Office of Intention to Grant Patent for AV-101 to Treat Neuropathic Pain
5:09pm
8-K
lmxn6u8f8qlix
9 Nov 23
Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results
4:42pm
8-K/A
ocarv
6 Nov 23
Other Events
9:46pm
8-K
ljrf1
6 Nov 23
Other Events
4:27pm
8-K
qs3ahz91uq895c9ga
26 Oct 23
Departure of Directors or Certain Officers
4:13pm
8-K
qdc8j3y9a8207oknwb
4 Oct 23
Entry into a Material Definitive Agreement
4:07pm
8-K
v6ylc7oyywg
2 Oct 23
Other Events
7:15am
8-K
mbn arwerqgjcy
29 Sep 23
Submission of Matters to a Vote of Security Holders
4:26pm
8-K
1x06lbshek6
12 Sep 23
Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH80 for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
8:43pm
8-K
ba53oa
8 Sep 23
Vistagen to receive $1.5 million and Fuji to obtain time-limited exclusive negotiation period for the Japanese market
5:27pm
8-K
ka7x2dwu
22 Aug 23
Vistagen Appoints Cindy Anderson as Chief Financial Officer
8:40am
8-K
qroy3 b6jr
10 Aug 23
Results of Operations and Financial Condition
4:49pm
8-K
zxw9tb3wqphpx92cp
7 Aug 23
Vistagen Announces Positive Top-Line Results from Phase 3
8:35am
8-K
9h7gvcl 3ocaq0
18 Jul 23
Other Events
6:02am
8-K
2j20txze9sg
13 Jul 23
Vistagen Receives Notice of Allowance for AV-101 Canadian Patent for Treatment of Dyskinesia Related to Levodopa Therapy for Parkinson’s Disease
4:35pm
8-K
is8d3q
7 Jul 23
Departure of Directors or Certain Officers
4:30pm